Daré Bioscience, Inc.DARENASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank64
3Y CAGR-7.0%
5Y CAGR+6.7%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-7.0%/yr
vs +20.8%/yr prior
5Y CAGR
+6.7%/yr
Recent deceleration
Acceleration
-27.8pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$9.05M-1.1%
2024$9.16M-23.1%
2023$11.91M+5.9%
2022$11.24M+34.6%
2021$8.35M+27.5%
2020$6.55M+13.2%
2019$5.79M+9.6%
2018$5.28M+95.2%
2017$2.71M-73.9%
2016$10.36M-